Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated September 04, 2023, titled "Press Release regarding our Subsidiary Caplin Steriles Limited, which has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA).".